On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexesElectronic supplementary information (ESI) available: Synthesis, characterization data and biological study details. CCDC 950001. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c3cc46239k

Smart design and efficient synthesis of benzimidazole Ru, Ir and Rh cyclometalated complexes are reported with promising cytotoxic activity against HT29, T47D, A2780 and A2780cisR cancer cell lines. Their apoptosis, accumulation, cell cycle arrest, protein binding and DNA binding effects are also di...

Full description

Saved in:
Bibliographic Details
Main Authors Yellol, Gorakh S, Donaire, Antonio, Yellol, Jyoti G, Vasylyeva, Vera, Janiak, Christoph, Ruiz, José
Format Journal Article
LanguageEnglish
Published 14.11.2013
Online AccessGet full text

Cover

More Information
Summary:Smart design and efficient synthesis of benzimidazole Ru, Ir and Rh cyclometalated complexes are reported with promising cytotoxic activity against HT29, T47D, A2780 and A2780cisR cancer cell lines. Their apoptosis, accumulation, cell cycle arrest, protein binding and DNA binding effects are also discussed. Organometallic complexes with smartly designed benzimidazole ligands exhibit promising anticancer activity towards a variety of cancer cell lines.
Bibliography:For ESI and crystallographic data in CIF or other electronic format see DOI
10.1039/c3cc46239k
950001
Electronic supplementary information (ESI) available: Synthesis, characterization data and biological study details. CCDC
ISSN:1359-7345
1364-548X
DOI:10.1039/c3cc46239k